Company / Assets per Share
Adaptimmune Therapeutics PLC Assets per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.18
FY2024
5-year range
$0.18 / $0.71
FY2020-FY2024
Trend
-37.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 4 consecutive years, from $0.71 in FY2020 to $0.18 in FY2024.
Based on SEC 10-K filings.
0.18 in FY2024 with a 5-year CAGR of -9.0%.
Declined from $0.35 to $0.18 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -29.1%
- 5-Year CAGR
- -9.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Adaptimmune Therapeutics PLC's assets per share has declined for 4 consecutive years.
- In FY2024, assets per share decreased 37.0% year-over-year.
- Peak assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.18 | -37.0% |
| FY2023 | $0.29 | -19.2% |
| FY2022 | $0.35 | -29.9% |
| FY2021 | $0.51 | -29.3% |
| FY2020 | $0.71 | +147.1% |
| FY2019 | $0.29 | -41.2% |
| FY2018 | $0.49 | -25.6% |
| FY2017 | $0.66 | +19.9% |
| FY2016 | $0.55 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026